Cryoport (CYRX) Asset Writedowns and Impairment (2014 - 2024)

Cryoport (CYRX) has 10 years of Asset Writedowns and Impairment data on file, last reported at $63.8 million in Q2 2024.

• Asset Writedowns and Impairment for Q2 2024 came in at $63.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $64.0 million (changed N/A YoY), and the FY2024 annual result was $63.8 million, up 28.73% from the prior year.
• Asset Writedowns and Impairment rose to $63.8 million in Q2 2024 per CYRX's latest filing, from $221000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $63.8 million in Q2 2024 and troughed at -$237000.0 in Q4 2021.
• A 4-year average of $4.9 million and a median of $31000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2020 and 2021: Asset Writedowns and Impairment soared 156570.59% in 2020, then plunged 278.2% in 2021.
• A 4-year view of Asset Writedowns and Impairment shows it stood at $133000.0 in 2020, then sank by 278.2% to -$237000.0 in 2021, then surged by 193.25% to $221000.0 in 2022, then surged by 28772.85% to $63.8 million in 2024.
• Business Quant data shows CYRX's Asset Writedowns and Impairment at $63.8 million in Q2 2024, $221000.0 in Q4 2022, and -$22000.0 in Q3 2022.